25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANVS (Annovis Bio Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Annovis Bio Inc together

I guess you are interested in Annovis Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Annovis Bio Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Annovis Bio Inc’s Price Targets

I'm going to help you getting a better view of Annovis Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Annovis Bio Inc

I send you an email if I find something interesting about Annovis Bio Inc.

1. Quick Overview

1.1. Quick analysis of Annovis Bio Inc (30 sec.)










1.2. What can you expect buying and holding a share of Annovis Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.23
Expected worth in 1 year
$2.64
How sure are you?
27.6%

+ What do you gain per year?

Total Gains per Share
$1.41
Return On Investment
59.6%

For what price can you sell your share?

Current Price per Share
$2.36
Expected price per share
$1.11 - $4.21
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Annovis Bio Inc (5 min.)




Live pricePrice per Share (EOD)
$2.36
Intrinsic Value Per Share
$-20,401.20 - $-24,520.30
Total Value Per Share
$-20,399.97 - $-24,519.07

2.2. Growth of Annovis Bio Inc (5 min.)




Is Annovis Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$24m$4m$5.5m57.9%

How much money is Annovis Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.2m-$11.8m$4.6m63.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Annovis Bio Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#496 / 884

Most Revenue
#773 / 884

Most Profit
#491 / 884

Most Efficient
#248 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Annovis Bio Inc?

Welcome investor! Annovis Bio Inc's management wants to use your money to grow the business. In return you get a share of Annovis Bio Inc.

First you should know what it really means to hold a share of Annovis Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Annovis Bio Inc is $2.36. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Annovis Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Annovis Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.23. Based on the TTM, the Book Value Change Per Share is $0.35 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Annovis Bio Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.28-12.0%-0.37-15.8%-0.61-25.8%-0.50-21.3%-0.37-15.5%-0.26-10.9%
Usd Book Value Change Per Share0.7632.1%0.3514.9%-0.30-12.8%-0.08-3.3%0.031.5%0.041.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.7632.1%0.3514.9%-0.30-12.8%-0.08-3.3%0.031.5%0.041.7%
Usd Price Per Share1.50-5.09-13.60-10.72-16.07-11.19-
Price to Earnings Ratio-1.32--3.55--17.22--9.19--22.59--16.72-
Price-to-Total Gains Ratio1.98-33.37-118.35-27.27--39.51--37.49-
Price to Book Ratio1.22--7.53--18.74--5.48-7.94-5.67-
Price-to-Total Gains Ratio1.98-33.37-118.35-27.27--39.51--37.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.36
Number of shares423
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.350.03
Usd Total Gains Per Share0.350.03
Gains per Quarter (423 shares)148.7414.50
Gains per Year (423 shares)594.9658.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1059558505848
20119011800116106
30178517750174164
40238023700232222
50297529650290280
60357035600348338
70416541550406396
80476047500464454
90535553450522512
100595059400580570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.029.00.00.0%0.033.00.00.0%
Book Value Change Per Share4.00.00.0100.0%6.06.00.050.0%7.013.00.035.0%8.018.03.027.6%9.021.03.027.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.033.00.0%
Total Gains per Share4.00.00.0100.0%6.06.00.050.0%7.013.00.035.0%8.018.03.027.6%9.021.03.027.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Annovis Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7570.352+115%-0.301+140%-0.077+110%0.034+2107%0.040+1814%
Book Value Per Share--1.2340.496+149%0.209+490%0.721+71%0.977+26%0.630+96%
Current Ratio--10.6784.543+135%4.465+139%7.200+48%15.782-32%11.459-7%
Debt To Asset Ratio--0.1000.572-82%0.907-89%0.538-81%0.350-71%8.141-99%
Debt To Equity Ratio--0.1120.410-73%0.159-30%0.245-54%0.180-38%0.135-17%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--48782475.000106142614.000-54%263966409.250-82%218876216.750-78%329700609.100-85%317278188.000-85%
Eps---0.284-0.373+31%-0.610+115%-0.502+77%-0.366+29%-0.256-10%
Ev To Ebitda Ratio---1.941-4.644+139%-6.567+238%-7.658+295%-22.482+1058%-23.464+1109%
Free Cash Flow Per Share---415.636-104.100-75%-0.416-100%-34.949-92%-21.009-95%-14.492-97%
Free Cash Flow To Equity Per Share--599.617149.999+300%-0.137+100%49.863+1103%180.722+232%124.656+381%
Gross Profit Margin--1.000132.935-99%1.0000%44.978-98%27.387-96%19.198-95%
Intrinsic Value_10Y_max---24520.301----------
Intrinsic Value_10Y_min---20401.200----------
Intrinsic Value_1Y_max---475.895----------
Intrinsic Value_1Y_min---466.280----------
Intrinsic Value_3Y_max---2939.786----------
Intrinsic Value_3Y_min---2776.081----------
Intrinsic Value_5Y_max---7224.056----------
Intrinsic Value_5Y_min---6575.226----------
Market Cap45987432.000+36%29229300.00099136042.500-71%264914889.000-89%208843348.500-86%313211435.700-91%218023700.483-87%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio1.912+36%1.215-7.531+720%-18.738+1642%-5.478+551%7.944-85%5.667-79%
Pe Ratio-2.076-57%-1.320-3.549+169%-17.218+1205%-9.193+597%-22.588+1612%-16.719+1167%
Price Per Share2.360+36%1.5005.088-71%13.595-89%10.718-86%16.074-91%11.189-87%
Price To Free Cash Flow Ratio-0.001-57%-0.001-5.884+652094%-8.101+897813%-8.793+974485%-27.058+2998935%-19.180+2125760%
Price To Total Gains Ratio3.119+36%1.98233.373-94%118.349-98%27.268-93%-39.515+2094%-37.489+1991%
Quick Ratio--8.880589.111-98%2.838+213%201.244-96%132.092-93%91.652-90%
Return On Assets---0.207-0.626+202%-1.043+403%-0.698+237%-0.492+137%-0.548+165%
Return On Equity---0.230-0.662+188%-0.668+190%-0.615+167%-0.454+97%-0.322+40%
Total Gains Per Share--0.7570.352+115%-0.301+140%-0.077+110%0.034+2107%0.040+1814%
Usd Book Value--24054000.0009668615.500+149%4073992.750+490%14051373.083+71%19041112.600+26%12282844.034+96%
Usd Book Value Change Per Share--0.7570.352+115%-0.301+140%-0.077+110%0.034+2107%0.040+1814%
Usd Book Value Per Share--1.2340.496+149%0.209+490%0.721+71%0.977+26%0.630+96%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--48782475.000106142614.000-54%263966409.250-82%218876216.750-78%329700609.100-85%317278188.000-85%
Usd Eps---0.284-0.373+31%-0.610+115%-0.502+77%-0.366+29%-0.256-10%
Usd Free Cash Flow---8099164000.000-2028506463.000-75%-8109001.750-100%-681031609.750-92%-409376684.150-95%-282397904.793-97%
Usd Free Cash Flow Per Share---415.636-104.100-75%-0.416-100%-34.949-92%-21.009-95%-14.492-97%
Usd Free Cash Flow To Equity Per Share--599.617149.999+300%-0.137+100%49.863+1103%180.722+232%124.656+381%
Usd Market Cap45987432.000+36%29229300.00099136042.500-71%264914889.000-89%208843348.500-86%313211435.700-91%218023700.483-87%
Usd Price Per Share2.360+36%1.5005.088-71%13.595-89%10.718-86%16.074-91%11.189-87%
Usd Profit---5537000.000-7265000.000+31%-11883434.500+115%-10435016.417+88%-7529135.050+36%-5266522.138-5%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share--0.7570.352+115%-0.301+140%-0.077+110%0.034+2107%0.040+1814%
 EOD+6 -2MRQTTM+19 -14YOY+20 -123Y+19 -145Y+20 -1310Y+17 -16

3.3 Fundamental Score

Let's check the fundamental score of Annovis Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.076
Price to Book Ratio (EOD)Between0-11.912
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.880
Current Ratio (MRQ)Greater than110.678
Debt to Asset Ratio (MRQ)Less than10.100
Debt to Equity Ratio (MRQ)Less than10.112
Return on Equity (MRQ)Greater than0.15-0.230
Return on Assets (MRQ)Greater than0.05-0.207
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Annovis Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.340
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Fundamental data was last updated by Penke on 2025-06-20 19:44:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Annovis Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM--141.4%+141.4%
YOY--186.1%+186.1%
3Y--248.3%+248.3%
5Y--338.6%+338.6%
10Y--488.9%+488.9%
4.3.1.2. Return on Assets

Shows how efficient Annovis Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • -20.7% Return on Assets means that Annovis Bio Inc generated $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Annovis Bio Inc:

  • The MRQ is -20.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -62.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.7%TTM-62.6%+41.9%
TTM-62.6%YOY-104.3%+41.7%
TTM-62.6%5Y-49.2%-13.4%
5Y-49.2%10Y-54.8%+5.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.7%-11.5%-9.2%
TTM-62.6%-11.6%-51.0%
YOY-104.3%-11.4%-92.9%
3Y-69.8%-11.8%-58.0%
5Y-49.2%-12.1%-37.1%
10Y-54.8%-13.8%-41.0%
4.3.1.3. Return on Equity

Shows how efficient Annovis Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • -23.0% Return on Equity means Annovis Bio Inc generated $-0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Annovis Bio Inc:

  • The MRQ is -23.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -66.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.0%TTM-66.2%+43.2%
TTM-66.2%YOY-66.8%+0.5%
TTM-66.2%5Y-45.4%-20.8%
5Y-45.4%10Y-32.2%-13.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.0%-13.6%-9.4%
TTM-66.2%-14.9%-51.3%
YOY-66.8%-14.4%-52.4%
3Y-61.5%-17.0%-44.5%
5Y-45.4%-17.9%-27.5%
10Y-32.2%-20.1%-12.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Annovis Bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Annovis Bio Inc is operating .

  • Measures how much profit Annovis Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--250.3%+250.3%
YOY--205.1%+205.1%
3Y--220.2%+220.2%
5Y--342.6%+342.6%
10Y--475.5%+475.5%
4.3.2.2. Operating Ratio

Measures how efficient Annovis Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.704-2.704
YOY-3.063-3.063
3Y-3.576-3.576
5Y-4.713-4.713
10Y-6.512-6.512
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Annovis Bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Annovis Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.68 means the company has $10.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Annovis Bio Inc:

  • The MRQ is 10.678. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.543. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.678TTM4.543+6.134
TTM4.543YOY4.465+0.078
TTM4.5435Y15.782-11.238
5Y15.78210Y11.459+4.323
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6783.661+7.017
TTM4.5433.786+0.757
YOY4.4654.121+0.344
3Y7.2004.680+2.520
5Y15.7825.765+10.017
10Y11.4596.150+5.309
4.4.3.2. Quick Ratio

Measures if Annovis Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.88 means the company can pay off $8.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Annovis Bio Inc:

  • The MRQ is 8.880. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 589.111. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.880TTM589.111-580.231
TTM589.111YOY2.838+586.273
TTM589.1115Y132.092+457.019
5Y132.09210Y91.652+40.440
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8802.826+6.054
TTM589.1113.128+585.983
YOY2.8383.782-0.944
3Y201.2444.304+196.940
5Y132.0925.703+126.389
10Y91.6526.454+85.198
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Annovis Bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Annovis Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Annovis Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Annovis Bio Inc assets are financed with 10.0% credit (debt) and the remaining percentage (100% - 10.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.100. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.572. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.100TTM0.572-0.471
TTM0.572YOY0.907-0.335
TTM0.5725Y0.350+0.222
5Y0.35010Y8.141-7.792
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1000.324-0.224
TTM0.5720.347+0.225
YOY0.9070.327+0.580
3Y0.5380.339+0.199
5Y0.3500.349+0.001
10Y8.1410.382+7.759
4.5.4.2. Debt to Equity Ratio

Measures if Annovis Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 11.2% means that company has $0.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.112. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.410. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.112TTM0.410-0.299
TTM0.410YOY0.159+0.251
TTM0.4105Y0.180+0.231
5Y0.18010Y0.135+0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1120.383-0.271
TTM0.4100.436-0.026
YOY0.1590.410-0.251
3Y0.2450.446-0.201
5Y0.1800.460-0.280
10Y0.1350.509-0.374
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Annovis Bio Inc generates.

  • Above 15 is considered overpriced but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -1.32 means the investor is paying $-1.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Annovis Bio Inc:

  • The EOD is -2.076. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.320. Based on the earnings, the company is expensive. -2
  • The TTM is -3.549. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.076MRQ-1.320-0.757
MRQ-1.320TTM-3.549+2.229
TTM-3.549YOY-17.218+13.670
TTM-3.5495Y-22.588+19.039
5Y-22.58810Y-16.719-5.869
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.076-2.197+0.121
MRQ-1.320-2.027+0.707
TTM-3.549-2.527-1.022
YOY-17.218-3.733-13.485
3Y-9.193-3.717-5.476
5Y-22.588-6.036-16.552
10Y-16.719-6.649-10.070
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Annovis Bio Inc:

  • The EOD is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.884. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-0.001-0.001
MRQ-0.001TTM-5.884+5.883
TTM-5.884YOY-8.101+2.217
TTM-5.8845Y-27.058+21.174
5Y-27.05810Y-19.180-7.878
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.001-3.007+3.006
MRQ-0.001-2.704+2.703
TTM-5.884-3.627-2.257
YOY-8.101-4.334-3.767
3Y-8.793-5.070-3.723
5Y-27.058-8.532-18.526
10Y-19.180-9.305-9.875
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Annovis Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.22 means the investor is paying $1.22 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Annovis Bio Inc:

  • The EOD is 1.912. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.215. Based on the equity, the company is underpriced. +1
  • The TTM is -7.531. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.912MRQ1.215+0.697
MRQ1.215TTM-7.531+8.746
TTM-7.531YOY-18.738+11.207
TTM-7.5315Y7.944-15.476
5Y7.94410Y5.667+2.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9121.921-0.009
MRQ1.2151.843-0.628
TTM-7.5312.113-9.644
YOY-18.7382.467-21.205
3Y-5.4782.541-8.019
5Y7.9443.666+4.278
10Y5.6674.311+1.356
4.6.2. Total Gains per Share

2.4. Latest News of Annovis Bio Inc

Does Annovis Bio Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Annovis Bio Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-19
12:40
Annovis Announces NYSE Acceptance of Plan to Regain Listing ComplianceRead
2025-06-19
12:30
Annovis Announces NYSE Acceptance of Plan to Regain Listing ComplianceRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Annovis Bio Inc.

4.8.1. Institutions holding Annovis Bio Inc

Institutions are holding 16.026% of the shares of Annovis Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc3.325064792018164338.956
2025-03-31Two Sigma Investments LLC0.8530.00051662191552961421.734
2025-03-31Geode Capital Management, LLC0.783201526135304953.2813
2025-03-31BlackRock Inc0.51640100629-11350-10.1358
2025-03-31Merit Financial Group, LLC0.5020.002297816-700-0.7105
2025-03-31Two Sigma Advisers, LLC0.47690.000392921929210
2024-12-31Susquehanna International Group, LLP0.28390553122379275.4822
2024-12-31UBS Group AG0.25010.000148736468892538.6573
2025-03-31Greenwich Wealth Management LLC0.23660.0052461001414944.2834
2025-03-31Wescott Financial Advisory Group, LLC0.21350.00654160700
2025-03-31Northern Trust Corp0.2088040679789924.097
2025-03-31State Street Corp0.197203843500
2025-03-31Lokken Investment Group LLC0.150.0185292351100060.3236
2024-12-31Group One Trading, LP0.13450.000326206-26561-50.3364
2025-03-31Sterling Investment Advisors Ltd0.12020.008423416-558-2.3275
2025-03-31Renaissance Technologies Corp0.11190.000121800218000
2025-03-31SIMPLEX TRADING, LLC0.1036020184201840
2024-12-31Spears Abacus Advisors LLC0.10260.00212000000
2025-03-31Bridgeway Capital Management, LLC0.09960.000719400-2000-9.3458
2025-03-31Bank of New York Mellon Corp0.097801905800
Total 8.76680.04491708286+587453+34.4%

4.9.2. Funds holding Annovis Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.6205051062800
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.73740.00021436821316510.0868
2025-04-30Fidelity Extended Market Index0.45130.000487932-841-0.9474
2025-04-30Fidelity Series Total Market Index0.1153022471843860.1297
2025-03-31Northern Trust Extended Eq Market Idx0.10060.000419612788767.2665
2025-03-31NT Ext Equity Mkt Idx Fd - L0.10060.000419612788767.2665
2025-04-30Spartan Extended Market Index Pool F0.09390.0004182928414.8192
2025-04-30Fidelity Total Market Index0.091701786700
2025-05-31iShares Micro-Cap ETF0.08710.00521698000
2025-03-31Bridgeway Ultra-Small Company Market0.07850.023415300-5700-27.1429
2025-03-31Extended Equity Market Fund K0.05920.000111530350.3045
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.04990.000297207162279.9844
2025-04-30Spartan Total Market Index Pool G0.048309412346658.2913
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03880.000275665539273.261
2025-04-30Vanguard Balanced Index Inv0.02490484400
2025-03-31T. Rowe Price Extended Equity Market Idx0.02460.0008480000
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.02420.00044710191668.5755
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01430.0007279427940
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01430.0007279427940
2025-03-31U.S. Equity Market Fund F0.011102163-3-0.1385
Total 4.78650.0335932709+55380+5.9%

5.3. Insider Transactions

Insiders are holding 14.683% of the shares of Annovis Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-10-11Claudine BruckBUY18127.66
2021-10-11Maria-luisa MaccecchiniBUY1800027.61
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets26,737
Total Liabilities2,683
Total Stockholder Equity24,054
 As reported
Total Liabilities 2,683
Total Stockholder Equity+ 24,054
Total Assets = 26,737

Assets

Total Assets26,737
Total Current Assets26,737
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 22,236
Other Current Assets 4,508
Total Current Assets  (as reported)26,737
Total Current Assets  (calculated)26,745
+/- 8
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,504
Long-term Liabilities179
Total Stockholder Equity24,054
Total Current Liabilities
Accounts payable 1,370
Other Current Liabilities 1,134
Total Current Liabilities  (as reported)2,504
Total Current Liabilities  (calculated)2,504
+/- 0
Long-term Liabilities
Long-term Liabilities  (as reported)179
Long-term Liabilities  (calculated)0
+/- 179
Total Stockholder Equity
Common Stock2
Retained Earnings -140,387
Other Stockholders Equity 164,438
Total Stockholder Equity (as reported)24,054
Total Stockholder Equity (calculated)24,053
+/- 1
Other
Capital Stock2
Cash and Short Term Investments 22,236
Common Stock Shares Outstanding 17,431
Liabilities and Stockholders Equity 26,737
Net Debt -22,236
Net Invested Capital 24,054
Net Working Capital 24,233



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,835
2,613
2,185
1,926
0
0
0
51
431
300
380
1,117
11,441
10,201
9,402
8,119
5,965
49,496
47,650
46,001
43,297
36,525
32,487
36,022
25,547
22,816
10,223
10,208
7,813
5,046
14,362
13,926
26,737
26,73713,92614,3625,0467,81310,20810,22322,81625,54736,02232,48736,52543,29746,00147,65049,4965,9658,1199,40210,20111,4411,117380300431510001,9262,1852,6132,835
   > Total Current Assets 
1,593
1,478
1,145
986
347
0
0
51
400
149
99
748
11,441
10,201
9,402
8,119
5,965
49,496
47,650
46,001
43,297
36,525
32,487
36,022
25,547
22,816
10,223
10,208
7,813
5,046
14,362
13,926
26,737
26,73713,92614,3625,0467,81310,20810,22322,81625,54736,02232,48736,52543,29746,00147,65049,4965,9658,1199,40210,20111,4417489914940051003479861,1451,4781,593
       Cash And Cash Equivalents 
72
164
121
28
-347
0
0
35
337
105
56
2
11,120
9,763
8,841
8,075
5,603
49,224
47,455
45,686
42,669
35,974
31,987
28,378
16,759
15,725
6,355
5,755
3,137
3,998
12,637
10,552
22,236
22,23610,55212,6373,9983,1375,7556,35515,72516,75928,37831,98735,97442,66945,68647,45549,2245,6038,0758,8419,76311,1202561053373500-3472812116472
       Short-term Investments 
0
0
0
0
695
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,623,993
0
0
0012,623,99300000000000000000000000006950000
       Net Receivables 
1,474
1,255
981
919
0
0
0
0
0
0
0
735
38
199
425
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000004251993873500000009199811,2551,474
       Inventory 
23
22
21
20
0
0
0
0
0
0
0
0
278
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000002780000000020212223
       Other Current Assets 
24
38
23
19
0
0
0
12
60
38
36
4
283
232
130
38
356
262
185
73
360
284
198
105
207
7,092
3,868
4,454
4,676
313
1,725
3,366
4,508
4,5083,3661,7253134,6764,4543,8687,092207105198284360731852623563813023228343638601200019233824
   > Long-term Assets 
0
0
0
0
-347
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000037028115131000-3470000
       Property Plant Equipment 
65
63
64
64
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000064646365
       Intangible Assets 
1,177
1,071
976
876
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000008769761,0711,177
       Other Assets 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,048,688
1,724,946
0
4,501,078
4,501,07801,724,9461,048,688000000000000000003702811513100000000
> Total Liabilities 
174
105
102
216
0
0
0
7,645
8,207
8,421
8,755
9,694
749
703
281
578
1,597
884
1,121
1,507
1,256
1,299
2,527
7,699
5,411
2,074
3,565
17,959
11,167
6,797
7,298
4,618
2,683
2,6834,6187,2986,79711,16717,9593,5652,0745,4117,6992,5271,2991,2561,5071,1218841,5975782817037499,6948,7558,4218,2077,645000216102105174
   > Total Current Liabilities 
174
105
102
216
0
0
0
568
608
794
1,126
2,011
749
703
281
578
1,597
884
1,121
1,507
1,256
1,299
2,527
7,699
5,411
2,074
3,565
4,279
4,870
4,057
5,391
3,881
2,504
2,5043,8815,3914,0574,8704,2793,5652,0745,4117,6992,5271,2991,2561,5071,1218841,5975782817037492,0111,126794608568000216102105174
       Accounts payable 
174
105
102
216
0
0
0
68
10
0
425
1,234
55
124
140
342
825
115
290
688
929
902
1,846
3,961
4,153
1,173
1,926
1,293
4,107
3,395
4,099
2,306
1,370
1,3702,3064,0993,3954,1071,2931,9261,1734,1533,9611,846902929688290115825342140124551,23442501068000216102105174
       Other Current Liabilities 
0
0
0
0
0
0
0
500
598
794
701
777
695
578
141
237
772
769
831
818
327
398
681
3,737
1,258
901
1,638
2,986
763
663
2,030
1,575
1,134
1,1341,5752,0306637632,9861,6389011,2583,7376813983278188317697722371415786957777017945985000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
7,077
7,599
7,627
7,628
7,683
0
0
0
0
0
0
0
688
929
902
1,846
3,961
4,152,940
0
0
13,680
6,297
2,740
1,907
737
179
1797371,9072,7406,29713,680004,152,9403,9611,84690292968800000007,6837,6287,6277,5997,0770000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
496
497
498
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000050049849749600000000
       Other Liabilities 
0
0
0
0
0
0
0
0
27
53
53
106
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000010653532700000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003702811513100000000
> Total Stockholder Equity
2,661
2,507
2,083
1,710
-132
0
0
-7,594
-7,776
-8,121
-8,375
-8,576
10,692
9,498
9,121
7,541
4,368
48,612
46,530
44,495
42,040
35,226
29,961
28,324
20,136
20,743
6,658
-7,751
-3,354
-1,751
7,064
9,308
24,054
24,0549,3087,064-1,751-3,354-7,7516,65820,74320,13628,32429,96135,22642,04044,49546,53048,6124,3687,5419,1219,49810,692-8,576-8,375-8,121-7,776-7,59400-1321,7102,0832,5072,661
   Common Stock
57
57
57
57
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2111111111111111111110000000057575757
   Retained Earnings Total Equity0000000-73,329-63,7920-50,960-43,3390-28,726-22,812-19,963-17,439-14,239000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000-7,077-7,07700-7,07700-6,9660000
   Capital Surplus 
0
0
0
0
0
0
0
0
201
201
201
201
19,910
0
0
21,779
21,806
68,575
69,341
73,220
0
78,564
80,920
0
83,927
94,071
0
0
0
0
0
0
0
000000094,07183,927080,92078,564073,22069,34168,57521,80621,7790019,91020120120120100000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
1,267
1,262
1,240
1,250
0
0
0
14,154
-6,876
-7,077
14,154
201
19,910
21,026
21,655
21,779
21,806
68,575
69,341
73,220
76,660
78,564
80,920
82,377
83,927
94,071
94,703
102,507
107,971
114,594
136,046
144,156
164,438
164,438144,156136,046114,594107,971102,50794,70394,07183,92782,37780,92078,56476,66073,22069,34168,57521,80621,77921,65521,02619,91020114,154-7,077-6,87614,1540001,2501,2401,2621,267



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-26,695
Operating Income-26,695-26,695
 
Operating Expense (+$)
Research Development19,995
Selling General Administrative6,599
Selling And Marketing Expenses100
Operating Expense26,69526,694
 
Net Interest Income (+$)
Interest Income332
Interest Expense-0
Other Finance Cost-1,853
Net Interest Income-1,521
 
Pretax Income (+$)
Operating Income-26,695
Net Interest Income-1,521
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-24,590,375-28,800
EBIT - interestExpense = 0
-49,156,160
-24,590,375
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-24,590,375
Earnings Before Interest and Taxes (EBITDA)-22,737
 
After tax Income (+$)
Income Before Tax-24,590,375
Tax Provision-0
Net Income From Continuing Ops-24,590-24,590,375
Net Income-24,590,375
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses26,695
Total Other Income/Expenses Net2,1051,521
 

Technical Analysis of Annovis Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Annovis Bio Inc. The general trend of Annovis Bio Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Annovis Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Annovis Bio Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Annovis Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.18 < 3.48 < 4.21.

The bearish price targets are: 1.71 > 1.36 > 1.11.

Know someone who trades $ANVS? Share this with them.👇

Annovis Bio Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Annovis Bio Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Annovis Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Annovis Bio Inc.

Annovis Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartAnnovis Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Annovis Bio Inc. The current adx is .

Annovis Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Annovis Bio Inc.

Annovis Bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Annovis Bio Inc.

Annovis Bio Inc Daily Relative Strength Index (RSI) ChartAnnovis Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Annovis Bio Inc.

Annovis Bio Inc Daily Stochastic Oscillator ChartAnnovis Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Annovis Bio Inc.

Annovis Bio Inc Daily Commodity Channel Index (CCI) ChartAnnovis Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Annovis Bio Inc.

Annovis Bio Inc Daily Chande Momentum Oscillator (CMO) ChartAnnovis Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Annovis Bio Inc.

Annovis Bio Inc Daily Williams %R ChartAnnovis Bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Annovis Bio Inc.

Annovis Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Annovis Bio Inc.

Annovis Bio Inc Daily Average True Range (ATR) ChartAnnovis Bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Annovis Bio Inc.

Annovis Bio Inc Daily On-Balance Volume (OBV) ChartAnnovis Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Annovis Bio Inc.

Annovis Bio Inc Daily Money Flow Index (MFI) ChartAnnovis Bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Annovis Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Annovis Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Annovis Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.340
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Annovis Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Annovis Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Annovis Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Annovis Bio Inc

I send you an email if I find something interesting about Annovis Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Annovis Bio Inc.

Receive notifications about Annovis Bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.